Michael W. Nall - 02 Sep 2021 Form 4 Insider Report for BIOCEPT INC

Role
CEO & President, Director
Signature
/s/ Michael W. Nall
Issuer symbol
N/A
Transactions as of
02 Sep 2021
Net transactions value
$0
Form type
4
Filing time
02 Sep 2021, 21:56:58 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Employee Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 02 Sep 2021 Common Stock 100,000 $3.76 Direct F1
transaction BIOC Performance-Based Employee Stock Option (right to buy) Award $0 +80,000 $0.000000 80,000 02 Sep 2021 Common Stock 80,000 $3.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option shall vest monthly following the Vesting Commencement Date of 9/2/21 until fully vested on 9/2/2024.
F2 1/36th of the shares subject to the option shall vest monthly, commencing upon the Issuer's achievement of a specified corporate milestone.